Literature DB >> 31594019

[Update Giant Cell Arteriitis].

Claudia Dechant1, Hendrik Schulze-Koops1.   

Abstract

Giant cell arteriitis (GCA) is the most common systemic vasculitis in patients ≥  50 years. GCA belongs to the group of large vessel vasculitides. Clinical hallmarks of GCA are persistent localized headache, jaw claudication, limb claudication, symptoms of polymyalgia rheumatica, constitutional symptoms and acute visual symptoms. A fast track diagnostic workup and subsequent immediate treatment are crucial to avoid persistent ischemic lesions, particularly blindness. This article reviews the EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice and the 2018 update of the EULAR recommendations for the management of large vessel vasculitis with a focus on GCA and new data on the value of tocilizimab in the treatment of GCA. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31594019     DOI: 10.1055/a-0722-6620

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  1 in total

1.  Localized livedo racemosa as an indicator for giant cell arteritis.

Authors:  Katharina Drerup; Marcus Both; Thomas Schwarz
Journal:  JAAD Case Rep       Date:  2022-04-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.